Previous close | 0.4000 |
Open | 0.4000 |
Bid | 0.0000 |
Ask | 1.1000 |
Strike | 15.00 |
Expiry date | 2024-05-17 |
Day's range | 0.3000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | 25 |
Company to disclose new programs from existing unnamed pre-clinical pipelineCAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that the company will host a New Program and Platform event on Thursday, June 6, 2024 from 8:00 to 10:00 a.m. ET. During the event, the company will disclose new
Relay Therapeutics ( NASDAQ:RLAY ) First Quarter 2024 Results Key Financial Results Revenue: US$10.0m (up by US$9.78m...
Despite Net Loss, Relay Therapeutics Reports Significant Revenue Growth and Robust Pipeline Progress